Seaport Therapeutics SPTX Income Statement (2024-2026)

NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Seaport Therapeutics Quarterly Income Statement

Periods 8 quarters
Latest Sep 2026

Seaport Therapeutics reported revenue of $0.00B and net income of -$0.03B for the quarter ended Sep 2026, up 38.9% year over year. This income statement covers 8 quarters of results from Dec 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue 3.10M2.98M2.81M2.52M2.13M3.26M3.90M
Operating items
Research & DevelopmentR&D 10.53M13.41M20.45M21.43M24.62M23.89M
Selling, General & AdministrativeSG&A 5.65M5.06M4.99M27,330.30M6.11M41.19M6.45M
Other Operating ExpensesOther Opex 2.63M1.82M1.81M-27,303.10M1.99M3.02M2.61M
Operating ExpensesOpex 16.19M18.47M25.44M27.20M27.54M65.81M30.35M
Operating IncomeOp. Inc -16.19M-18.47M-25.44M-27.20M-27.54M-65.81M-30.35M
Non-operating items
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales 0.19M-0.06M0.10M0.08M-0.25M-0.56M-1.22M
Interest & Investment IncomeInt & Inv Inc 3.06M3.39M2.90M2.14M3.21M3.95M
Other Non Operating IncomeOther Non Op Inc. 0.01M0.06M0.04M0.02M0.05M0.03M0.01M
Non Operating IncomeNon Op. Inc. 3.09M3.53M2.99M3.58M2.65M3.46M4.08M
Net income details
EBIT -16.19M-18.47M-25.44M-27.20M-27.54M-65.81M-30.35M
EBT -13.09M-14.94M-22.45M-23.62M-24.89M-62.35M-26.27M
Tax ProvisionsTaxes 0.03M0.13M0.10M0.51M0.52M0.25M0.13M
Income After Tax -13.13M-15.08M-22.54M-24.14M-25.41M-62.60M-26.39M
Income from Continuing OperationsIncome (Continuing) -13.13M-15.08M-22.54M-24.14M-25.41M-62.60M-26.39M
Consolidated Net IncomeConsol Net Inc. -12.93M-15.14M-22.45M-24.06M-25.65M-63.14M-27.60M
Income towards Parent CompanyParent Net Inc -13.13M-15.08M-22.54M-24.14M-25.41M-62.60M-26.39M
Net Income towards Common StockholdersNet Income -13.13M-15.08M-22.54M-24.14M-25.41M-62.60M-26.39M
Additional items
EPS (Basic) -5.65-6.40-9.43-10.10-10.34-3.27-0.49
EPS (Diluted) -5.65-6.40-9.43-10.10-10.34-3.27-0.49
Shares Outstanding 2.32M2.36M2.39M2.39M2.46M19.12M53.53M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 2.32M2.36M2.39M2.39M2.46M19.12M53.53M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 2.59M2.59M2.59M2.59M2.60M2.60M19.12M53.53M
EBITDA -16.98M-19.61M-26.33M-27.16M-27.74M-66.14M-30.87M

Seaport Therapeutics Income Statement API

Pull Seaport Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SPTX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY